The One Stock That Will Be the Surprising Beneficiary of the "ASCO Effect"

Every year at about this time, we bring you a report on the annual meeting of the American Society of Clinical Oncology (ASCO) - an event that’s attended by 30,000 people and hosts 4,000 presentations.

We tell you about it because of the so-called ASCO Effect – a hefty surge in cancer-focused biotech stocks that always accompanies the start of this meeting.

Full Story